Adipocytokines during pregnancy and postpartum in women with gestational diabetes and healthy controls

被引:0
作者
M. Boyadzhieva
I. Atanasova
S. Zacharieva
S. Kedikova
机构
[1] Medical University Sofia,Clinical Center of Endocrinology
[2] Medical University Sofia,University Hospital of Obstetrics and Gynecology
来源
Journal of Endocrinological Investigation | 2013年 / 36卷
关键词
Gestational diabetes; adipocytokines; adiponectin; leptin; resistin; visfatin; apelin;
D O I
暂无
中图分类号
学科分类号
摘要
Background: This study aims to explore the changes in maternal serum adipocytokines during pregnancy and post partum in normal and complicated with gestational diabetes (GDM) pregnancies and to investigate the relationship between serum adipocytokines and some of major metabolic parameters. Materials and methods: 236 pregnant women (127 with GDM and 109 control group) and 50 postpartum women (30 with GDM during pregnancy and 20 controls). Using ELISA and EIA kits, serum levels of adipocytokines were tested during pregnancy and post partum. Maternal adipocytokines levels were correlated with some metabolic parameters. Results: Women with GDM had lower values of adiponectin and higher values of leptin during pregnancy (p<0.001; 0.0001) and post partum (p<0.002; 0.0001). Serum apelin was significantly lower in GDM group (p<0.009). However, we did not find significance for resistin (p<0.317) and apelin (p<0.218). Positive correlation for leptin and negative for adiponectin was found for pre-pregnancy and pregnancy body mass index, glycated hemoglobin and homeostasis model assessment of insulin resistance index. Using cut point of 8.2 µg/ml for adiponectin and 28.7 ng/ml for leptin could exclude GDM with a sensitivity of 83.6%/81.2% and specificity of 56.6%/64.2% (area under the curve 0.702 and 0.827). Conclusion: There are constant differences in adiponectin and leptin levels between GDM and control group during pregnancy and post partum. Apelin was decreased in our GDM group and no differences were found for resistin and visfatin. Further studies are required to verify the mechanism of this alteration and whether the adipocytokines can be predictors for GDM at an early stage of pregnancy.
引用
收藏
页码:944 / 949
页数:5
相关论文
共 123 条
[1]  
Sun WJ(2007)Maternal and fetal outcomes in pregnant women with abnormal glucose metabolism Zhonghua Fu Chan Ke Za Zhi 42 377-81
[2]  
Yang HX(2007)Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus Diabetes Care 30 S251-60
[3]  
Metzger BE(2012)Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia Clin Endocrinol (Oxf) 76 2-11
[4]  
Buchanan TA(2010)The effects of adipose tissue and adipocytokines in human pregnancy Ann NY Acad Sci 1205 76-81
[5]  
Coustan DR(2008)Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls Gynecol Endocrinol 24 614-9
[6]  
Miehle K(2009)Reviews: adipocytokines in normal and complicated pregnancies Reprod Sci 16 921-37
[7]  
Stepan H(2003)Adipocytokines, obesity and development of type 2 diabetes Med Sci (Paris) 19 809-17
[8]  
Fasshauer M(2007)Adiponectin — an adipokine with unique metabolic properties Nephrol Dial Transplant 22 981-8
[9]  
Valsamakis G(2011)Third trimester plasma adiponectin and leptin in gestational diabetes and normal pregnancies Diabetes Res Clin Pract 93 350-6
[10]  
Kumar S(2004)Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus Am J Obstet Gynecol 191 2120-4